Poclight Biotech develops dry chemiluminescence diagnostic products and related technologies.
Founded in 2019 and based in Nanjing, China, Poclight Biotech develops diagnostic products using chemiluminescence resonance energy transfer technology. Its products include dry immunoassays and freeze-dried reagent pellets for medical, veterinary, food, drug, and environmental applications. As of the third quarter of 2023, it had 66 NMPA registrations and 131 CE certifications. In November 2025, it raised Series B funding from returning investor Wenzhou Investment, with Gaoxin Huichuang participating, to support R&D, promotion, and market expansion.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in